Kandulu Chikondi C, Sahm Laura J, Saab Mohamad M, O'Driscoll Michelle, McCarthy Megan, Shorter Gillian W, Berry Emma, Moore Anne C, Fleming Aoife
Pharmaceutical Care Research Group, University College Cork, College Rd, T12 K8AF Cork, Ireland.
Mercy University Hospital, Grenville Place, T12 WE28 Cork, Ireland.
Vaccines (Basel). 2024 Sep 25;12(10):1093. doi: 10.3390/vaccines12101093.
: COVID-19 vaccines were rapidly developed and deployed on a large scale during a global crisis. A range of deployment strategies were used globally to maximize vaccine uptake. In this scoping review, we identify and analyze the main healthcare system and policy factors that guided and influenced COVID-19 vaccination deployment and uptake globally. : JBI guidelines, Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR), and the population, concept, and context (PCC) framework were applied. Studies on individual COVID-19 vaccination factors, such as vaccine hesitancy, were excluded. The search was last conducted in May 2024 yielding 26,686 articles from PubMed, Embase, CINAHL, Scopus, and COVID-19 websites. A total of 47 articles and 3 guidance documents were included. The results of the thematic analysis were mapped to the Consolidated Framework for Implementation Research (CFIR). : The results found the following healthcare system and policy factors as integral to COVID-19 vaccination: types of vaccine products, healthcare workforce capacity, procurement strategies, distribution and cold-chain capacity, partnership, coordination, and leadership, information, communication, and registration strategies, delivery models, organizations, the existing health systems and policies on prioritization of at-risk groups and deployment plans. : Globally, COVID-19 vaccination programs responded to the pandemic by leveraging and reforming the existing healthcare systems, relying on strong leadership and global cooperation (such as the COVID-19 Vaccines Global Access Initiative). Deployment was enabled by effective communication and adoption of innovative technologies using data-driven policies to create high vaccine demand while overcoming limited vaccine supply and rapidly adapting to uncertainties.
在全球危机期间,新冠疫苗迅速研发并大规模部署。全球采用了一系列部署策略以最大限度提高疫苗接种率。在本范围综述中,我们识别并分析了在全球范围内指导和影响新冠疫苗接种部署及接种率的主要医疗保健系统和政策因素。采用了循证卫生保健国际合作中心(JBI)指南、系统评价与Meta分析优先报告条目扩展版(PRISMA-ScR)以及人群、概念和背景(PCC)框架。排除了关于单个新冠疫苗接种因素(如疫苗犹豫)的研究。检索最近一次于2024年5月进行,从PubMed、Embase、护理学与健康领域数据库(CINAHL)、Scopus以及新冠相关网站中检索到26686篇文章。共纳入47篇文章和3份指导文件。主题分析结果映射到实施研究综合框架(CFIR)。结果发现以下医疗保健系统和政策因素是新冠疫苗接种不可或缺的:疫苗产品类型、医护人员能力、采购策略、分发及冷链能力、伙伴关系、协调与领导力、信息、沟通及登记策略、交付模式、组织、现有的卫生系统以及关于高危人群优先排序和部署计划的政策。在全球范围内,新冠疫苗接种计划通过利用和改革现有的医疗保健系统来应对疫情,依靠强有力的领导和全球合作(如新冠疫苗全球获取倡议)。通过有效的沟通以及采用创新技术并运用数据驱动政策来创造高疫苗需求,同时克服疫苗供应有限的问题并迅速适应不确定性,从而实现了疫苗部署。